Chinese Journal of Dermatology ›› 2019, Vol. 52 ›› Issue (7): 502-505.doi: 10.3760/cma.j.issn.0412-4030.2019.07.014
• Reviews • Previous Articles Next Articles
Chen Yiwen, Su Ting, Su Zhonglan
Received:2018-12-25
Revised:2019-02-20
Online:2019-07-15
Published:2019-07-01
Contact:
Su Zhonglan
E-mail:alice_su2595@126.com
Supported by:Chen Yiwen, Su Ting, Su Zhonglan. Association between psoriasis and STAT3[J].Chinese Journal of Dermatology, 2019, 52(7): 502-505.
| ［1］ | Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology［J］. J Am Acad Dermatol, 2017,76（3）:377⁃390. doi: 10.1016/j.jaad.2016.07.064. |
| ［2］ | Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities［J］. Dermatol Clin, 2015,33（1）:41⁃55. doi: 10.1016/j.det.2014.09.004. |
| ［3］ | Parisi R, Webb RT, Kleyn CE, et al. Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study［J］. Br J Dermatol, 2019,180（1）:108⁃115. doi: 10.1111/bjd.17004. |
| ［4］ | Kamstrup MR, Skov L, Zachariae C, et al. Psoriasis and risk of malignant lymphoma: a population⁃based cohort study［J］. Br J Dermatol, 2018,178（6）:1435⁃1436. doi: 10.1111/bjd.16245. |
| ［5］ | Eppinga H, Poortinga S, Thio HB, et al. Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease［J］. Inflamm Bowel Dis, 2017,23（10）:1783⁃1789. doi: 10.1097/MIB.0000000000001169. |
| ［6］ | Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model［J］. Nat Med, 2005,11（1）:43⁃49. doi: 10.1038/nm1162. |
| ［7］ | Albanesi C, Madonna S, Gisondi P, et al. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis［J］. Front Immunol, 2018,9:1549. doi: 10.3389/fimmu. 2018.01549. |
| ［8］ | 蔡明龙, 王文俊, 张学军. 银屑病全基因组关联分析与精准医学［J］. 中华皮肤科杂志, 2018,51（10）:715⁃719. doi: 10.3760/cma.j.issn.0412⁃4030.2018.10.002. |
| ［9］ | Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review［J］. J Autoimmun, 2015,64:66⁃73. doi: 10.1016/j.jaut.2015.07.008. |
| ［10］ | Zeng J, Luo S, Huang Y, et al. Critical role of environmental factors in the pathogenesis of psoriasis［J］. J Dermatol, 2017,44（8）:863⁃872. doi: 10.1111/1346⁃8138.13806. |
| ［11］ | Jin L, Wang G. Keratin 17: a critical player in the pathogenesis of psoriasis［J］. Med Res Rev, 2014,34（2）:438⁃454. doi: 10.1002/ med.21291. |
| ［12］ | Lande R, Botti E, Jandus C, et al. The antimicrobial peptide LL37 is a T⁃cell autoantigen in psoriasis［J］. Nat Commun, 2014,5:5621. doi: 10.1038/ncomms6621. |
| ［13］ | Furue K, Yamamura K, Tsuji G, et al. Highlighting interleukin⁃36 signalling in plaque psoriasis and pustular psoriasis［J］. Acta Derm Venereol, 2018,98（1）:5⁃13. doi: 10.2340/00015555⁃2808. |
| ［14］ | 王刚. 中性粒细胞：银屑病研究新热点［J］. 中华皮肤科杂志, 2018,51（10）:711⁃714. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 10.001. |
| ［15］ | Darnell JE. STATs and gene regulation［J］. Science, 1997,277（5332）:1630⁃1635. |
| ［16］ | Hillmer EJ, Zhang H, Li HS, et al. STAT3 signaling in immunity［J］. Cytokine Growth Factor Rev, 2016,31:1⁃15. doi: 10.1016/j.cytogfr.2016.05.001. |
| ［17］ | Mertens C, Darnell JE. SnapShot: JAK⁃STAT signaling［J］. Cell, 2007,131（3）:612. doi: 10.1016/j.cell.2007.10.033. |
| ［18］ | Yu H, Lee H, Herrmann A, et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions［J］. Nat Rev Cancer, 2014,14（11）:736⁃746. doi: 10.1038/nrc3818. |
| ［19］ | Timofeeva OA, Chasovskikh S, Lonskaya I, et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA［J］. J Biol Chem, 2012,287（17）:14192⁃14200. doi: 10. 1074/jbc.M111.323899. |
| ［20］ | Bromberg J. Stat proteins and oncogenesis［J］. J Clin Invest, 2002,109（9）:1139⁃1142. doi: 10.1172/JCI15617. |
| ［21］ | Camporeale A, Poli V. IL⁃6, IL⁃17 and STAT3: a holy trinity in auto⁃immunity?［J］. Front Biosci （Landmark Ed）, 2012,17:2306⁃2326. |
| ［22］ | Egwuagu CE. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases［J］. Cytokine, 2009,47（3）:149⁃156. doi: 10.1016/j.cyto.2009.07.003. |
| ［23］ | Zheng Y, Danilenko DM, Valdez P, et al. Interleukin⁃22, a T（H）17 cytokine, mediates IL⁃23⁃induced dermal inflammation and acanthosis［J］. Nature, 2007,445（7128）:648⁃651. doi: 10.1038/nature05505. |
| ［24］ | Zhang B, Xie S, Su Z, et al. Heme oxygenase⁃1 induction attenuates imiquimod⁃induced psoriasiform inflammation by negative regulation of Stat3 signaling［J］. Sci Rep, 2016,6:21132. doi: 10.1038/srep21132. |
| ［25］ | Shi X, Jin L, Dang E, et al. IL⁃17A upregulates keratin 17 in keratinocytes through STAT1⁃ and STAT3⁃dependent mechanisms［J］. J Invest Dermatol, 2011,131（12）:2401⁃2408. doi: 10.1038/jid.2011.222. |
| ［26］ | Müller A, Hennig A, Lorscheid S, et al. IκBζ is a key transcriptional regulator of IL⁃36⁃driven psoriasis⁃related gene in keratinocytes［J］. Proc Natl Acad Sci U S A, 2018,115（40）:10088⁃10093. doi: 10.1073/pnas.1801377115. |
| ［27］ | Xia YP, Li B, Hylton D, et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis［J］. Blood, 2003,102（1）:161⁃168. doi: 10.1182/blood⁃2002⁃12⁃3793. |
| ［28］ | Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up⁃regulates VEGF and tumor angiogenesis［J］. Oncogene, 2002,21（13）:2000⁃2008. doi: 10.1038/sj.onc.1205260. |
| ［29］ | Miyoshi K, Takaishi M, Nakajima K, et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA⁃21, a Stat3 inhibitor［J］. J Invest Dermatol, 2011,131（1）:108⁃117. doi: 10.1038/jid.2010.255. |
| ［30］ | Xu Y, Ji Y, Lan X, et al. miR⁃203 contributes to IL⁃17⁃induced VEGF secretion by targeting SOCS3 in keratinocytes［J］. Mol Med Rep, 2017,16（6）:8989⁃8996. doi: 10.3892/mmr.2017.7759. |
| ［31］ | Yan JJ, Qiao M, Li RH, et al. Downregulation of miR⁃145⁃5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis［J］. Br J Dermatol, 2019,180（2）:365⁃372. doi: 10.1111/bjd.17256. |
| ［32］ | Valenzuela F, Korman NJ, Bissonnette R, et al. Tofacitinib in patients with moderate⁃to⁃severe chronic plaque psoriasis: long⁃term safety and efficacy in an open⁃label extension study［J］. Br J Dermatol, 2018,179（4）:853⁃862. doi: 10.1111/bjd.16798. |
| ［33］ | Hosking AM, Juhasz M, Mesinkovska NA. Topical Janus kinase inhibitors: a review of applications in dermatology［J］. J Am Acad Dermatol, 2018,79（3）:535⁃544. doi: 10.1016/j.jaad.2018. 04.018. |
| [1] | Shen Jia, Yuan Huijie, Pan Meng. Role of eosinophils in the pathogenesis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2019, 52(8): 579-581. |
| [2] | Lu Xuya, Xu Qiang, Li Pinchuan, Zhang Zhaohui. Diagnosis and treatment of painful leg ulcers [J]. Chinese Journal of Dermatology, 2019, 52(7): 510-514. |
| [3] | Li Lingjia, Liu Tongyun . Expression of caspase-14 in skin lesions of patients with chronic actinic dermatitis and effect of ultraviolet B radiation on its mRNA and protein expression in HaCaT cells [J]. Chinese Journal of Dermatology, 2019, 52(7): 486-490. |
| [4] | Su Beibei, Gan Quan, Gan Caibin. Effects of metformin on inflammatory status and phosphorylated Stat3 expression in lesions of a psoriasis?like mouse model [J]. Chinese Journal of Dermatology, 2019, 52(7): 475-480. |
| [5] | Li Yumei, Zhang Yixuan, Liu Liping. Induced pluripotent stem cells: advances in research and application in dermatology [J]. Chinese Journal of Dermatology, 2019, 52(7): 445-449. |
| [6] | Qin Hui, Zheng Jie. FTY720 ameliorates psoriasis by inhibiting infiltration of skin Interleukin 17-producing γδT cells [J]. Chinese Journal of Dermatology, 2019, 52(6): 395-400. |
| [7] | Xie Yun, Chen Mingliang, Zhao Shuang, Liu Dihui, Li Fangfang . Photodynamic therapy for scrotal lymphangioma: a case report [J]. Chinese Journal of Dermatology, 2019, 52(5): 330-331. |
| [8] | Wang Liwei, Luo Lingling, Cui Pan′gen, Li Min. Relationship between intestinal flora and psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 357-360. |
| [9] | Yu Lijuan, Lyu Zhongfa. JAK inhibitors for the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2019, 52(5): 343-346. |
| [10] | Hu Yu, Chen Min, Gu Heng. MicroRNA and lncRNA in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 350-353. |
| [11] | Pan Jiaxu, Zhou Jing. NF?κB signaling pathway in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 361-363. |
| [12] | Shou Yanhong, Zhang Zhen, Luo Xiaoqun, Chen Sheng′an, Li Feng, Zhu Xiaohua, Lin Jinran, Qin Haihong, Du Juan, Chen Sunyi, Yang Yongsheng, Xu Jinhua . Effect of interferon-γ combined with tumor necrosis factor-related apoptosis-inducing ligand on programmed necrosis of HaCaT cells and its mechanisms [J]. Chinese Journal of Dermatology, 2019, 52(5): 302-309. |
| [13] | Zhang Shaolong, Chang Yuqian, Lin Xingxiao, Su Xin, Jian Zhe, Li Chunying. Application of camouflage therapy in vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 283-285. |
| [14] | Zeng Jingxin, Tian Xin, Zhu Huilan, Zhang Xibao, Lin Ling, Zhang Lidan, Liu Weiyu, Luo Quan . Expression of miRNA-148a-3p in CD4+ T lymphocytes in peripheral blood of patients with psoriasis vulgaris and its clinical significance [J]. Chinese Journal of Dermatology, 2019, 52(4): 231-235. |
| [15] | Lei Jiehao, Fan Qimin, Chen Rong, Xu Ai′e. Association between efficacy of and response to narrow-band ultraviolet B phototherapy as well as factors related to phototherapy response in patients with vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 259-262. |
|
